KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $2.8 billion.

  • Eli Lilly's Long-Term Investments fell 1224.61% to $2.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year decrease of 1224.61%. This contributed to the annual value of $3.2 billion for FY2024, which is 536.33% up from last year.
  • Eli Lilly's Long-Term Investments amounted to $2.8 billion in Q3 2025, which was down 1224.61% from $3.2 billion recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Long-Term Investments ranged from a high of $3.5 billion in Q2 2021 and a low of $2.6 billion during Q3 2022
  • For the 5-year period, Eli Lilly's Long-Term Investments averaged around $3.0 billion, with its median value being $3.1 billion (2023).
  • As far as peak fluctuations go, Eli Lilly's Long-Term Investments surged by 5043.51% in 2021, and later tumbled by 2554.61% in 2022.
  • Over the past 5 years, Eli Lilly's Long-Term Investments (Quarter) stood at $3.2 billion in 2021, then fell by 9.67% to $2.9 billion in 2022, then grew by 5.18% to $3.1 billion in 2023, then grew by 5.36% to $3.2 billion in 2024, then decreased by 12.67% to $2.8 billion in 2025.
  • Its Long-Term Investments was $2.8 billion in Q3 2025, compared to $3.2 billion in Q2 2025 and $3.2 billion in Q1 2025.